152 related articles for article (PubMed ID: 11929837)
1. Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy.
Dolmans DE; Kadambi A; Hill JS; Waters CA; Robinson BC; Walker JP; Fukumura D; Jain RK
Cancer Res; 2002 Apr; 62(7):2151-6. PubMed ID: 11929837
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy.
Dolmans DE; Kadambi A; Hill JS; Flores KR; Gerber JN; Walker JP; Borel Rinkes IH; Jain RK; Fukumura D
Cancer Res; 2002 Aug; 62(15):4289-94. PubMed ID: 12154031
[TBL] [Abstract][Full Text] [Related]
3. Assessment of photosensitizer dosimetry and tissue damage assay for photodynamic therapy in advanced-stage tumors.
Sheng C; Pogue BW; Wang E; Hutchins JE; Hoopes PJ
Photochem Photobiol; 2004 Jun; 79(6):520-5. PubMed ID: 15291303
[TBL] [Abstract][Full Text] [Related]
4. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
[TBL] [Abstract][Full Text] [Related]
5. Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy.
He C; Agharkar P; Chen B
Pharm Res; 2008 Aug; 25(8):1873-80. PubMed ID: 18446275
[TBL] [Abstract][Full Text] [Related]
6. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
7. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
[TBL] [Abstract][Full Text] [Related]
8. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.
Chen B; Pogue BW; Hoopes PJ; Hasan T
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1216-26. PubMed ID: 15752904
[TBL] [Abstract][Full Text] [Related]
9. Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.
Thong PSP; Lee K; Toh HJ; Dong J; Tee CS; Low KP; Chang PH; Bhuvaneswari R; Tan NC; Soo KC
Oncotarget; 2017 Mar; 8(12):19902-19913. PubMed ID: 28423634
[TBL] [Abstract][Full Text] [Related]
10. DH-I-180-3-mediated photodynamic therapy: biodistribution and tumor vascular damage.
Lim DS; Ko SH; Lee CH; Ahn WS; Lee WY
Photochem Photobiol; 2006; 82(2):600-5. PubMed ID: 16613519
[TBL] [Abstract][Full Text] [Related]
11. F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth.
Acker G; Palumbo A; Neri D; Vajkoczy P; Czabanka M
J Neurooncol; 2016 Aug; 129(1):33-8. PubMed ID: 27188647
[TBL] [Abstract][Full Text] [Related]
12. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy.
Chen B; Crane C; He C; Gondek D; Agharkar P; Savellano MD; Hoopes PJ; Pogue BW
Int J Cancer; 2008 Aug; 123(3):695-701. PubMed ID: 18498134
[TBL] [Abstract][Full Text] [Related]
13. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence and photodynamic effects of bacteriochlorin a observed in vivo in 'sandwich' observation chambers.
van Leengoed HL; Schuitmaker JJ; van der Veen N; Dubbelman TM; Star WM
Br J Cancer; 1993 May; 67(5):898-903. PubMed ID: 8494722
[TBL] [Abstract][Full Text] [Related]
15. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
16. The effects of thrombocytopenia on vessel stasis and macromolecular leakage after photodynamic therapy using photofrin.
Fingar VH; Wieman TJ; Haydon PS
Photochem Photobiol; 1997 Oct; 66(4):513-7. PubMed ID: 9337624
[TBL] [Abstract][Full Text] [Related]
17. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer.
Kuzyniak W; Schmidt J; Glac W; Berkholz J; Steinemann G; Hoffmann B; Ermilov EA; Gürek AG; Ahsen V; Nitzsche B; Höpfner M
Int J Oncol; 2017 Mar; 50(3):953-963. PubMed ID: 28098886
[TBL] [Abstract][Full Text] [Related]
18. Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane.
Nowak-Sliwinska P; van Beijnum JR; van Berkel M; van den Bergh H; Griffioen AW
Angiogenesis; 2010 Dec; 13(4):281-92. PubMed ID: 20842454
[TBL] [Abstract][Full Text] [Related]
19. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
Roberts WG; Hasan T
Cancer Res; 1993 Jan; 53(1):153-7. PubMed ID: 8416739
[TBL] [Abstract][Full Text] [Related]
20. Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.
de Bruijn HS; Mashayekhi V; Schreurs TJL; van Driel PBAA; Strijkers GJ; van Diest PJ; Lowik CWGM; Seynhaeve ALB; Hagen TLMT; Prompers JJ; Henegouwen PMPVBE; Robinson DJ; Oliveira S
Theranostics; 2020; 10(5):2436-2452. PubMed ID: 32089747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
